MENU
LGND
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ligand Pharmaceuticals (LGND) Ownership - Who owns Ligand Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
555 Heritage Drive
Phone
+1 858 550-7500
Employees
58
Web
https://www.ligand.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.28B
P/E Ratio
48.37
Total Cash
N/A
Projected Growth
N/A
Total Debt
6.19M
Revenue
N/A
Risk (Beta)
1.10
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
8.88
Revenue/Share
8.31 USD as % of share price
Fundamentals
LGND
Capitalization
2.28B
P/E Ratio
48.37
Risk (Beta)
1.10
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
6.19M
Total Debt/Equity
8.88
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
8.31%
Revenue
N/A
ROE
N/A
Book Value
807M
P/B Ratio
2.70
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
18K
Current Ratio
20.70
Current Revenue Per Employee
534103.44
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
90.70
Revenue To Assets
N/A
Shares Held By Institutions
3.52B
Shares Outstanding - Current
18.9M
Total Liabilities
107M
Total Volume MTD
N/A
Value
-1
Gain YTD
68.622
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
555 Heritage Drive
Phone
+1 858 550-7500
Employees
58
Web
https://www.ligand.com